Our Full Geistlich Portfolio
A sheet matrix for the office. A particulate collagen scaffold for the hospital. Two FDA 510(k)‑cleared, porcine-derived solutions, each designed for a different clinical setting.
Office-Based Solution
Derma-Gide is an FDA-cleared porcine-derived device for wound management. It provides an optimized structure for cell migration, vascularization, and cell attachment and has robust clinical evidence supporting its efficacy.1,2
Explore Derma-Gide
Hospital-Based Solution
DermaForm is a uniquely engineered particulate device that provides a scaffold for your patients' wound needs — a structure to support the wound as it heals. Designed to manage large, complex hospital wounds, DermaForm gives clinicians a new option in advanced wound care.
Explore DermaFormAbout Geistlich
Geistlich is a global leader dedicated to advancing regenerative medicine. The company has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 120 distributors, the company reaches over 100 markets and employs around 900 people.
1. Armstrong DG et al. Functional Properties of a Purified Reconstituted Bilayer Matrix Design Support Natural Wound Healing Activities. Plast Reconstr Surg Glob Open. 2021 May 21;9(5):e3596. doi: 10.1097/GOX.0000000000003596. 2. Armstrong DG et al. A Purified Reconstituted Bilayer Matrix Shows Improved Outcomes in Treatment of Non-healing Diabetic Foot Ulcers When Compared to the Standard of Care: Final Results and Analysis of a Prospective, Randomized, Controlled, Multi-centre Clinical Trial. Int Wound J. 2024 Apr;21(4):e14882. doi: 10.1111/iwj.14882.